These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 29345897)

  • 1. Design, Synthesis, and Biological Evaluation of 1-Benzylamino-2-hydroxyalkyl Derivatives as New Potential Disease-Modifying Multifunctional Anti-Alzheimer's Agents.
    Panek D; Więckowska A; Jończyk J; Godyń J; Bajda M; Wichur T; Pasieka A; Knez D; Pišlar A; Korabecny J; Soukup O; Sepsova V; Sabaté R; Kos J; Gobec S; Malawska B
    ACS Chem Neurosci; 2018 May; 9(5):1074-1094. PubMed ID: 29345897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, Synthesis, and Biological Evaluation of 2-(Benzylamino-2-Hydroxyalkyl)Isoindoline-1,3-Diones Derivatives as Potential Disease-Modifying Multifunctional Anti-Alzheimer Agents.
    Panek D; Więckowska A; Pasieka A; Godyń J; Jończyk J; Bajda M; Knez D; Gobec S; Malawska B
    Molecules; 2018 Feb; 23(2):. PubMed ID: 29414887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual Inhibitors of Amyloid-β and Tau Aggregation with Amyloid-β Disaggregating Properties: Extended
    Pasieka A; Panek D; Szałaj N; Espargaró A; Więckowska A; Malawska B; Sabaté R; Bajda M
    ACS Chem Neurosci; 2021 Jun; 12(11):2057-2068. PubMed ID: 34019757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Multitarget-Directed Ligands Aiming at Symptoms and Causes of Alzheimer's Disease.
    Więckowska A; Wichur T; Godyń J; Bucki A; Marcinkowska M; Siwek A; Więckowski K; Zaręba P; Knez D; Głuch-Lutwin M; Kazek G; Latacz G; Mika K; Kołaczkowski M; Korabecny J; Soukup O; Benkova M; Kieć-Kononowicz K; Gobec S; Malawska B
    ACS Chem Neurosci; 2018 May; 9(5):1195-1214. PubMed ID: 29384656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of multifunctional anti-Alzheimer's agents with a unique mechanism of action including inhibition of the enzyme butyrylcholinesterase and γ-aminobutyric acid transporters.
    Pasieka A; Panek D; Jończyk J; Godyń J; Szałaj N; Latacz G; Tabor J; Mezeiova E; Chantegreil F; Dias J; Knez D; Lu J; Pi R; Korabecny J; Brazzolotto X; Gobec S; Höfner G; Wanner K; Więckowska A; Malawska B
    Eur J Med Chem; 2021 Jun; 218():113397. PubMed ID: 33838585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of novel multifunctional ligands targeting GABA transporters, butyrylcholinesterase, β-secretase, and amyloid β aggregation as potential treatment of Alzheimer's disease.
    Zaręba P; Łątka K; Mazur G; Gryzło B; Pasieka A; Godyń J; Panek D; Skrzypczak-Wiercioch A; Höfner GC; Latacz G; Maj M; Espargaró A; Sabaté R; Jóźwiak K; Wanner KT; Sałat K; Malawska B; Kulig K; Bajda M
    Eur J Med Chem; 2023 Dec; 261():115832. PubMed ID: 37837674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1-Benzylpyrrolidine-3-amine-based BuChE inhibitors with anti-aggregating, antioxidant and metal-chelating properties as multifunctional agents against Alzheimer's disease.
    Wichur T; Więckowska A; Więckowski K; Godyń J; Jończyk J; Valdivieso ÁDR; Panek D; Pasieka A; Sabaté R; Knez D; Gobec S; Malawska B
    Eur J Med Chem; 2020 Feb; 187():111916. PubMed ID: 31812794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and biological evaluation of some 2-(3-oxo-5,6-diphenyl-1,2,4-triazin-2(3H)-yl)-N-phenylacetamide hybrids as MTDLs for Alzheimer's disease therapy.
    Waiker DK; Verma A; Gajendra TA; Namrata ; Roy A; Kumar P; Trigun SK; Srikrishna S; Krishnamurthy S; Davisson VJ; Shrivastava SK
    Eur J Med Chem; 2024 May; 271():116409. PubMed ID: 38663285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pterostilbene-O-acetamidoalkylbenzylamines derivatives as novel dual inhibitors of cholinesterase with anti-β-amyloid aggregation and antioxidant properties for the treatment of Alzheimer's disease.
    Li Y; Qiang X; Li Y; Yang X; Luo L; Xiao G; Cao Z; Tan Z; Deng Y
    Bioorg Med Chem Lett; 2016 Apr; 26(8):2035-9. PubMed ID: 26947607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel drug-like fluorenyl derivatives as selective butyrylcholinesterase and β-amyloid inhibitors for the treatment of Alzheimer's disease.
    Pasieka A; Panek D; Zaręba P; Sługocka E; Gucwa N; Espargaró A; Latacz G; Khan N; Bucki A; Sabaté R; Więckowska A; Malawska B
    Bioorg Med Chem; 2023 Jun; 88-89():117333. PubMed ID: 37236021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and evaluation of novel ferulic acid-O-alkylamine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.
    Sang Z; Pan W; Wang K; Ma Q; Yu L; Yang Y; Bai P; Leng C; Xu Q; Li X; Tan Z; Liu W
    Eur J Med Chem; 2017 Apr; 130():379-392. PubMed ID: 28279845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationship studies of benzyl-, phenethyl-, and pyridyl-substituted tetrahydroacridin-9-amines as multitargeting agents to treat Alzheimer's disease.
    Osman W; Mohamed T; Sit VM; Vasefi MS; Beazely MA; Rao PP
    Chem Biol Drug Des; 2016 Nov; 88(5):710-723. PubMed ID: 27282589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New cyclopentaquinoline hybrids with multifunctional capacities for the treatment of Alzheimer's disease.
    Czarnecka K; Girek M; Maciejewska K; Skibiński R; Jończyk J; Bajda M; Kabziński J; Sołowiej P; Majsterek I; Szymański P
    J Enzyme Inhib Med Chem; 2017 Dec; 33(1):158-170. PubMed ID: 29210299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel deoxyvasicinone derivatives as potent multitarget-directed ligands for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation.
    Ma F; Du H
    Eur J Med Chem; 2017 Nov; 140():118-127. PubMed ID: 28923380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological evaluation of synthetic α,β-unsaturated carbonyl based cyclohexanone derivatives as neuroprotective novel inhibitors of acetylcholinesterase, butyrylcholinesterase and amyloid-β aggregation.
    Zha GF; Zhang CP; Qin HL; Jantan I; Sher M; Amjad MW; Hussain MA; Hussain Z; Bukhari SN
    Bioorg Med Chem; 2016 May; 24(10):2352-9. PubMed ID: 27083471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of Novel Pyrazolopyrimidinone Derivatives as Phosphodiesterase 9A Inhibitors Capable of Inhibiting Butyrylcholinesterase for Treatment of Alzheimer's Disease.
    Yu YF; Huang YD; Zhang C; Wu XN; Zhou Q; Wu D; Wu Y; Luo HB
    ACS Chem Neurosci; 2017 Nov; 8(11):2522-2534. PubMed ID: 28783948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and evaluation of pterostilbene β-amino alcohol derivatives as multifunctional agents for Alzheimer's disease treatment.
    Zheng Y; Qiang X; Xu R; Song Q; Tian C; Liu H; Li W; Tan Z; Deng Y
    Bioorg Chem; 2018 Aug; 78():298-306. PubMed ID: 29625269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of 1-(phenylsulfonyl)-1H-indole-based multifunctional ligands targeting cholinesterases and 5-HT
    Wichur T; Pasieka A; Godyń J; Panek D; Góral I; Latacz G; Honkisz-Orzechowska E; Bucki A; Siwek A; Głuch-Lutwin M; Knez D; Brazzolotto X; Gobec S; Kołaczkowski M; Sabate R; Malawska B; Więckowska A
    Eur J Med Chem; 2021 Dec; 225():113783. PubMed ID: 34461507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and characterization of 1H-phenanthro[9,10-d]imidazole derivatives as multifunctional agents for treatment of Alzheimer's disease.
    Liu J; Qiu J; Wang M; Wang L; Su L; Gao J; Gu Q; Xu J; Huang SL; Gu LQ; Huang ZS; Li D
    Biochim Biophys Acta; 2014 Sep; 1840(9):2886-903. PubMed ID: 24821011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and biological evaluation of 2-arylethenylquinoline derivatives as multifunctional agents for the treatment of Alzheimer's disease.
    Wang XQ; Xia CL; Chen SB; Tan JH; Ou TM; Huang SL; Li D; Gu LQ; Huang ZS
    Eur J Med Chem; 2015 Jan; 89():349-61. PubMed ID: 25462251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.